Literature DB >> 24550059

Using absolute risks to assess the risks and benefits of treatment.

Mitchell H Gail.   

Abstract

Entities:  

Keywords:  COPD Exacerbations; COPD Pharmacology; Clinical Epidemiology

Mesh：

Substances：

Year:  2014        PMID： 24550059      PMCID： PMC4686127          DOI： 10.1136/thoraxjnl-2014-205175

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  4 in total

1.  Using multiple risk models with preventive interventions.

Authors:  Mitchell H Gail
Journal:  Stat Med       Date:  2012-06-26       Impact factor: 2.373

Review 2.  Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Authors:  M H Gail; J P Costantino; J Bryant; R Croyle; L Freedman; K Helzlsouer; V Vogel
Journal:  J Natl Cancer Inst       Date:  1999-11-03       Impact factor: 13.506

3.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

4.  Benefits and harms of roflumilast in moderate to severe COPD.

Authors:  Tsung Yu; Kevin Fain; Cynthia M Boyd; Sonal Singh; Carlos O Weiss; Tianjing Li; Ravi Varadhan; Milo A Puhan
Journal:  Thorax       Date:  2013-12-17       Impact factor: 9.139
  4 in total
  2 in total

Review 1.  Patient-centered care for people living with multimorbidity.

Authors:  Cynthia M Boyd; Gregory M Lucas
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

2.  Using a patient-centered approach to benefit-harm assessment in treatment decision-making: a case study in uveitis.

Authors:  Tsung Yu; Janet T Holbrook; Jennifer E Thorne; Milo A Puhan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-22       Impact factor: 2.890
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.